Choi CM, Bogart M, Wee SA, Burstein R, Arndt K, Dover J. Predicting migraine responsiveness to botulinum toxin type A injections. Arch Dermatol. 2010;146(2): 159-163.
Wee SA, Dover JS. Effective treatment of psychotropic drug-induced facial hyperpigmentation with a 755-nm Q-switched Alexandrite laser . Dermatol Surg. 2008;34(11):1609-12.
Kaminer MS, Bogart M, Choi C, Wee SA. Long-term efficacy of anchored barbed sutures in the face and neck. Dermatol Surg. 2008; 34(8):1041-7.
Fang M, Wee SA, Ronski K, Fan H, Tao S, Lin Q. Evidence of EGR1 as a differentially expressed gene among proliferative skin diseases. Genomic Med. 2007; 1(1-2):–85.
Wee SA. Multiple eruptive keratoacanthomas, de novo. Dermatol Online J. 2004 Nov 30;10(3):19.
Wee SA, Possick P. Necrobiosis lipoidica. Dermatol Online J. 2004 Nov 30;10(3):18.
Beynet DP, Wee SA, Horwitz SS, Kohler S, Horning S, Hoppe R, Kim YH. Clinical and pathological features of posttransplantation lymphoproliferative disorders presenting with skin involvement in 4 patients. Arch Dermatol. 2004 Sep; 140(9):1140-6 (also oral presentation at The Dermatologic Society of Greater New York 2005).
Wee SA, Lin Q, Tao S, Fan H, Khavari PA. Profiling genomic expression in disorders of epidermal proliferation identifies Egr-1 as a potent regulator of epidermal growth. J Invest Dermatol. 2001;117(2):477.
Dajee M, Wee SA, Tao S, Khavari PA. Non-invasive topical immunization by a peptide vaccine against hepatitis B and rubella virus. J Invest Dermatol 2001; 117(2): 435.
Fan H, Wee SA, Khavari PA (abstract and poster). Sonic hedgehog opposes epithelial cell cycle arrest. J Invest Dermatol 1999; 112(4):525.